Works matching IS 03656233 AND DT 2022 AND VI 355 AND IP 2

Results: 12

Design, synthesis, and biological evaluation of coumarin analogs as novel LSD1 inhibitors.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100311

By:

Sun, Yixiang;
Lv, Ruicheng;
Wu, Tianxiao;
Zhang, Xiangyu;
Sun, Yin;
Yan, Jiangkun;
Zhang, Ziheng;
Zhao, Dongmei;
Cheng, Maosheng

Publication type:

Article

Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4‐b]pyridines with potential p38α MAPK‐inhibitory activity.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100302

By:

Farahat, Aya A.;
Samir, Eman M.;
Zaki, Mayssoune Y.;
Serya, Rabah A. T.;
Abdel‐Aziz, Hatem A.

Publication type:

Article

Editorial Board: Arch Pharm (2/2022).

Published in:: Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202270004
Publication type:: Article

Cover Picture: Arch Pharm (2/2022).

Published in:: Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202270003
Publication type:: Article

Development of methylated cobalt–alkyne complexes with selective cytotoxicity against COX‐positive cancer cell lines.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100408

By:

Baecker, Daniel;
Sagasser, Jessica;
Karaman, Serhat;
Hörmann, Anton Amadeus;
Gust, Ronald

Publication type:

Article

Biology‐oriented drug synthesis and evaluation of secnidazole esters as novel enzyme ınhibitors.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100376

By:

Ansari, Muhammad A.;
Saad, Syed M.;
Khan, Khalid M.;
Salar, Uzma;
Taslimi, Parham;
Taskın‐Tok, Tugba;
Saleem, Faiza;
Jahangir, Sajid

Publication type:

Article

Design, synthesis, and biological evaluation of novel morpholinated isatin–quinoline hybrids as potent anti‐breast cancer agents.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100368

By:

Singh, Atamjit;
Kaur, Harneetpal;
Arora, Saroj;
Bedi, Preet Mohinder Singh

Publication type:

Article

Effective chiral pool synthesis of both enantiomers of the TRPML inhibitor trans‐ML‐SI3.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100362

By:

Kriegler, Katharina;
Leser, Charlotte;
Mayer, Peter;
Bracher, Franz

Publication type:

Article

Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100359

By:

Alsaif, Nawaf A.;
Mahdy, Hazem A.;
Alanazi, Mohammed M.;
Obaidullah, Ahmad J.;
Alkahtani, Hamad M.;
Al‐Hossaini, Abdullah M.;
Al‐Mehizi, Abdulrahman A.;
Elwan, Alaa;
Taghour, Mohammed S.

Publication type:

Article

Pharmacological report of recently designed multifunctional coumarin and coumarin–heterocycle derivatives.

Published in:: Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100345
Publication type:: Article

Antiprotozoal agents: How have they changed over a decade?

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100338

By:

Fernandes, Vitória de Souza;
da Rosa, Rafael;
Zimmermann, Lara A.;
Rogério, Kamilla R.;
Kümmerle, Arthur E.;
Bernardes, Lilian S. C.;
Graebin, Cedric S.

Publication type:

Article

Design, synthesis, anticancer, and docking of some S‐ and/or N‐heterocyclic derivatives as VEGFR‐2 inhibitors.

Published in:

Archiv der Pharmazie, 2022, v. 355, n. 2, p. 1, doi. 10.1002/ardp.202100237

By:

El‐Adl, Khaled;
Abdel‐Rahman, Adel A.‐H.;
Omar, Asmaa M.;
Alswah, Mohamed;
Saleh, Nashwa M.

Publication type:

Article